BusinessRemedy Pharmaceuticals Co-founder and CEO Brings Clinical Trial and Company-Building Experience to ReNetX Bio Advisory BoardBy Nasdaq OMXFeb 12, 2018, 3:00 PM UTC
BusinessPredictive Technology Group Appoints Dr. Hugh S. Taylor, M.D. to the Predictive Technology Group's Scientific Advisory BoardBy Nasdaq OMXJan 4, 2018, 2:02 PM UTC
BusinessA New Program at Yale Takes Aim at Opioid and other Substance Abuse using EntrepreneurshipBy Nasdaq OMXNov 15, 2017, 3:55 PM UTC
BusinessReNetX Bio Receives $7M Commitment from Wings for Life to Bring Spinal Cord Treatment to TrialBy Nasdaq OMXNov 7, 2017, 6:00 PM UTC
BusinessSENS Research Foundation Announces New Research Program on Developing Monoclonal Antibodies Against Glucosepane With David Spiegel LabBy Nasdaq OMXSep 18, 2017, 3:00 PM UTC
BusinessFamily Office Exchange Launches 2017 Webinar Series with “Investors Chasing Yale and the Future of Alpha”By Nasdaq OMXJan 26, 2017, 4:00 PM UTC
